Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Apr 23;308(6936):1087–1091. doi: 10.1136/bmj.308.6936.1087

Diagnosis and management of pituitary tumours.

A Levy 1, S L Lightman 1
PMCID: PMC2539974  PMID: 8080517

Full text

PDF
1089

Images in this article

1088p1088-a
on p.1088

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bevan J. S., Webster J., Burke C. W., Scanlon M. F. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev. 1992 May;13(2):220–240. doi: 10.1210/edrv-13-2-220. [DOI] [PubMed] [Google Scholar]
  2. Jaffe C. A., Barkan A. L. Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am. 1992 Sep;21(3):713–735. [PubMed] [Google Scholar]
  3. Jones K. L. The Cushing syndromes. Pediatr Clin North Am. 1990 Dec;37(6):1313–1332. doi: 10.1016/s0031-3955(16)37013-4. [DOI] [PubMed] [Google Scholar]
  4. Lamberts S. W., Hofland L. J., de Herder W. W., Kwekkeboom D. J., Reubi J. C., Krenning E. P. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Front Neuroendocrinol. 1993 Jan;14(1):27–55. doi: 10.1006/frne.1993.1002. [DOI] [PubMed] [Google Scholar]
  5. Levy A., Lightman S. L. The pathogenesis of pituitary adenomas. Clin Endocrinol (Oxf) 1993 Jun;38(6):559–570. doi: 10.1111/j.1365-2265.1993.tb02136.x. [DOI] [PubMed] [Google Scholar]
  6. Littley M. D., Shalet S. M., Beardwell C. G. Radiation and hypothalamic-pituitary function. Baillieres Clin Endocrinol Metab. 1990 Mar;4(1):147–175. doi: 10.1016/s0950-351x(05)80321-0. [DOI] [PubMed] [Google Scholar]
  7. Losa M., Oeckler R., Schopohl J., Müller O. A., Alba-Lopez J., von Werder K. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. J Neurosurg. 1989 Apr;70(4):561–567. doi: 10.3171/jns.1989.70.4.0561. [DOI] [PubMed] [Google Scholar]
  8. Lüdecke D. K. Transnasal microsurgery of Cushing's disease 1990. Overview including personal experiences with 256 patients. Pathol Res Pract. 1991 Jun;187(5):608–612. doi: 10.1016/S0344-0338(11)80155-X. [DOI] [PubMed] [Google Scholar]
  9. Molitch M. E. Management of prolactinomas. Annu Rev Med. 1989;40:225–232. doi: 10.1146/annurev.me.40.020189.001301. [DOI] [PubMed] [Google Scholar]
  10. Mountcastle R. B., Roof B. S., Mayfield R. K., Mordes D. B., Sagel J., Biggs P. J., Rawe S. E. Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci. 1989 Aug;298(2):109–118. doi: 10.1097/00000441-198908000-00007. [DOI] [PubMed] [Google Scholar]
  11. Snyder P. J. Clinically nonfunctioning pituitary adenomas. Endocrinol Metab Clin North Am. 1993 Mar;22(1):163–175. [PubMed] [Google Scholar]
  12. Tran L. M., Blount L., Horton D., Sadeghi A., Parker R. G. Radiation therapy of pituitary tumors: results in 95 cases. Am J Clin Oncol. 1991 Feb;14(1):25–29. doi: 10.1097/00000421-199102000-00005. [DOI] [PubMed] [Google Scholar]
  13. Webster J., Piscitelli G., Polli A., D'Alberton A., Falsetti L., Ferrari C., Fioretti P., Giordano G., L'Hermite M., Ciccarelli E. Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group. Clin Endocrinol (Oxf) 1992 Dec;37(6):534–541. doi: 10.1111/j.1365-2265.1992.tb01485.x. [DOI] [PubMed] [Google Scholar]
  14. Wilson C. B. Role of surgery in the management of pituitary tumors. Neurosurg Clin N Am. 1990 Jan;1(1):139–159. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES